Quick Answer
REGENTIS BIOMATERIALS LTD. reported Net Income of -$13.65 million for fiscal year 2025.
REGENTIS BIOMATERIALS LTD. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net Income | -$13.65M -384.3% |
$4.80M +216.2% |
-$4.13M | — |
| Diluted EPS | -$24.16 -1504.7% |
$1.72 +107.1% |
-$24.09 | — |
| Total Assets | $7.62M +1480.5% |
$482.0K | — | — |
| Stockholders Equity | $4.74M +111.5% |
-$41.10M +10.5% |
-$45.91M -9.1% |
-$42.06M |
| Operating Income | -$6.97M -847.6% |
$932.0K +148.3% |
-$1.93M | — |
| Shares Outstanding | 5.18M +3093.2% |
162,198 | — | — |
- REGENTIS BIOMATERIALS LTD. reported Net Income of -$13.65 million for fiscal year 2025.
- REGENTIS BIOMATERIALS LTD. showed a decrease of -384.3% in Net Income compared to the prior fiscal year.
- REGENTIS BIOMATERIALS LTD. reported Diluted EPS of $24.16 per share (loss) for fiscal year 2025.
- REGENTIS BIOMATERIALS LTD. showed a decrease of -1504.7% in Diluted EPS compared to the prior fiscal year.
- REGENTIS BIOMATERIALS LTD. reported Total Assets of $7.62 million for fiscal year 2025.
- REGENTIS BIOMATERIALS LTD. showed an increase of +1480.5% in Total Assets compared to the prior fiscal year.
- REGENTIS BIOMATERIALS LTD. reported Stockholders Equity of $4.74 million for fiscal year 2025.
- REGENTIS BIOMATERIALS LTD. showed an increase of +111.5% in Stockholders Equity compared to the prior fiscal year.
- REGENTIS BIOMATERIALS LTD. reported Operating Income of -$6.97 million for fiscal year 2025.
- REGENTIS BIOMATERIALS LTD. showed a decrease of -847.6% in Operating Income compared to the prior fiscal year.
- REGENTIS BIOMATERIALS LTD. reported Shares Outstanding of 5.18 million shares for fiscal year 2025.
- REGENTIS BIOMATERIALS LTD. showed an increase of +3093.2% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: